- Home
- PLBY vs ADAP Comparison
PLBY vs ADAP Comparison
Compare PLBY & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- ADAP
- Stock Information
- Founded
- PLBY 1953
- ADAP 2008
- Country
- PLBY United States
- ADAP United Kingdom
- Employees
- PLBY N/A
- ADAP N/A
- Industry
- PLBY Recreational Games/Products/Toys
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- ADAP Health Care
- Exchange
- PLBY Nasdaq
- ADAP Nasdaq
- Market Cap
- PLBY 142.4M
- ADAP 158.6M
- IPO Year
- PLBY N/A
- ADAP 2015
- Fundamental
- Price
- PLBY $1.81
- ADAP $0.58
- Analyst Decision
- PLBY Buy
- ADAP Strong Buy
- Analyst Count
- PLBY 2
- ADAP 4
- Target Price
- PLBY $2.35
- ADAP $2.79
- AVG Volume (30 Days)
- PLBY 576.4K
- ADAP 2.3M
- Earning Date
- PLBY 11-12-2024
- ADAP 03-05-2025
- Dividend Yield
- PLBY N/A
- ADAP N/A
- EPS Growth
- PLBY N/A
- ADAP N/A
- EPS
- PLBY N/A
- ADAP N/A
- Revenue
- PLBY $124,761,000.00
- ADAP $175,041,000.00
- Revenue This Year
- PLBY N/A
- ADAP $204.91
- Revenue Next Year
- PLBY N/A
- ADAP N/A
- P/E Ratio
- PLBY N/A
- ADAP N/A
- Revenue Growth
- PLBY 30.09
- ADAP 146.27
- 52 Week Low
- PLBY $0.52
- ADAP $0.53
- 52 Week High
- PLBY $1.99
- ADAP $2.05
- Technical
- Relative Strength Index (RSI)
- PLBY 65.90
- ADAP 41.87
- Support Level
- PLBY $1.47
- ADAP $0.55
- Resistance Level
- PLBY $1.51
- ADAP $0.65
- Average True Range (ATR)
- PLBY 0.15
- ADAP 0.05
- MACD
- PLBY 0.03
- ADAP 0.00
- Stochastic Oscillator
- PLBY 74.63
- ADAP 31.31
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.